A membrane-type surfactant protein D (SP-D) suppresses macrophage-mediated cytotoxicity in swine endothelial cells

Transpl Immunol. 2018 Apr:47:44-48. doi: 10.1016/j.trim.2018.02.003. Epub 2018 Feb 6.

Abstract

Objective: Surfactant protein D (SP-D), which is secreted mainly in the lung, is an oligometric C type lectin that promotes phagocytosis by binding to carbohydrates on microbial surfaces. SP-D can also bind SIRPα, leading to a decrease in cytokine production by monocytes/macrophages. In the present study, we examined the possibility that SP-D suppresses macrophage-mediated xenogeneic cytotoxicity, by creating a membrane-type SP-D.

Methods: The cDNA for the carbohydrate recognition domain (CRD) of human SP-D was switched to that of a membrane-type protein, collectin placenta 1 (CL-P1), with a Flag-tag. The cDNA of CD47 was prepared as a control. The suppressive function of the membrane-type protein of the hybrid molecule, CL-SP-D, to monocytes/macrophages was then studied and the results compared with that for CD47.

Results: The expression of Flag-tagged CL-SP-D on the transfected SECs and the SIRPα on monocyte-like cells, THP-1 cells, was confirmed by FACS using anti-Flag Ab and anti-CD172a, respectively. The molecular size of the hybrid protein was next assessed by western blot. While significant cytotoxicity against SEC was induced in differentiated THP-1 cells, CL-SP-D significantly reduced THP-1-mediated cytotoxicity. In addition, phosphorylated SHP-1 was clearly detected in SEC/CL-SP-D in western blots. Moreover, IL-10 production was upregulated and IL-1β production was suppressed in the case of THP-1 and SEC/CL-SP-D, compared with naïve SEC. Next, the cytotoxicity caused by the in vitro generated macrophage was assessed under the same conditions as were used for THP-1. CL-SP-D also showed the significant down-regulation on the macrophage. In addition, changes in IL-10 production by the macrophage confirmed the results.

Conclusions: These findings indicate that the membrane-type SP-D serve as an effective therapeutic strategy for inhibiting macrophage-mediated xenograft rejection in xenotransplantation.

Keywords: Macrophage; SIRPα; SP-D; THP-1; Xenotransplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Differentiation / metabolism*
  • Antigens, Heterophile / immunology
  • Biological Therapy
  • Cells, Cultured
  • Collectins / genetics
  • Cytotoxicity, Immunologic
  • Endothelial Cells / physiology*
  • Graft Rejection / immunology*
  • Graft Rejection / therapy
  • Humans
  • Interleukin-10 / metabolism
  • Lung / immunology*
  • Macrophages / immunology*
  • Phagocytosis
  • Pulmonary Surfactant-Associated Protein D / genetics
  • Pulmonary Surfactant-Associated Protein D / metabolism*
  • Receptors, Immunologic / metabolism*
  • Receptors, Scavenger / genetics
  • Swine
  • THP-1 Cells
  • Transplantation, Heterologous*

Substances

  • Antigens, Differentiation
  • Antigens, Heterophile
  • COLEC12 protein, human
  • Collectins
  • Pulmonary Surfactant-Associated Protein D
  • Receptors, Immunologic
  • Receptors, Scavenger
  • SIRPA protein, human
  • Interleukin-10